Blueprint Medicines

Get Full Access

Description

  • Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets.We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients.We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients lives. We dont think in small steps. We think in giant leaps.We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
  • location

    Headquarters:45 Sidney Street , Cambridge, Massachusetts, United States

    More
  • Blueprint Medicines phone

    Phone Number: +1 617-374-7580

  • Blueprint Medicines website

    Website: https://www.blueprintmedicines.com

  • Blueprint Medicines employees

    Employees:434

  • Blueprint Medicines revenue

    Revenue:$500M - 1B

  • Blueprint Medicines legal name

    Legal Name:Blueprint Medicines

  • Blueprint Medicines's Social Media

    Blueprint Medicines linkedin Blueprint Medicines twitter
  • done Is this data correct?
  • |  NAICS Code: 541720  |

    Show More
Person level website identification

Executive Vices President And Chief Legal Officer for Blueprint Medicines

Tracey Mccain

Executive Vices President And Chief Legal Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Tracey Mccain

Executive Vices President And Chief Legal Officer

Helen Ho

Chief Business Officer

Fouad Namouni

President, Research And Development

Michael Landsittel

Chief Financial Officer

Debbie Durso-Bumpus

Chief People Officer

Frequently Asked Questions regarding Blueprint Medicines

  • Where are Blueprint Medicines's Headquarters?

    Blueprint Medicines's Headquarters are in 45 Sidney Street ,Cambridge,Massachusetts,United States

  • What is Blueprint Medicines's phone number?

    Blueprint Medicines's phone number is +1 617-374-7580

  • What is Blueprint Medicines's official website?

    Blueprint Medicines's official website is https://www.blueprintmedicines.com

  • What is Blueprint Medicines's Revenue?

    Blueprint Medicines's revenue is $500M - 1B

  • What is Blueprint Medicines's NAICS code?

    Blueprint Medicines's NAICS code is 541720

  • How many employees are working in Blueprint Medicines

    Blueprint Medicines has 434 employees

  • What is Blueprint Medicines's Industry?

    Blueprint Medicines is in the industry of Biotechnology

  • Who is Blueprint Medicines's Executive Vices President And Chief Legal Officer?

    Blueprint Medicines's Executive Vices President And Chief Legal Officer is Tracey Mccain

Company Directory